
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is a promising investment due to its strong financial performance, successful launch of new products, diverse client base and confident expansion plans. Additionally, the company's track record of winning contracts and investment in technology showcase their potential for continued growth and profitability. With a new price target of $33 and completed share repurchase program, Progyny's stock is expected to continue its positive trajectory.
Bears say
Progyny is a leading fertility management company with a strong competitive position, best-in-class retention, and a large potential addressable market. However, the recent decline in birth rates and the potential risks associated with entering the insurance market could hinder the company's growth potential. Additionally, while management emphasized a disciplined capital allocation framework, it is possible that the company may prioritize growth over profitability in the future.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares